English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > がん > 欧州の頭部癌・頸部癌治療市場
カテゴリ
医薬品 (4962)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州の頭部癌・頸部癌治療市場

European Head and Neck Cancer Therapeutics Markets

発行 Frost & Sullivan
出版日 2007年08月 商品コード 54134
ページ情報 英文 124 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the chemotherapy and targeted therapies markets.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Overview of the Head and Neck Cancer Therapeutics Market

2. GLOSSARY OF TERMS

List of Terms

  • Abbreviations

3. MARKET OVERVIEW

Introduction

  • Disease Characteristics
  • Epidemiology

Market Definition and Segmentation

  • Definition
  • Segmentation

4. RESEARCH METHODOLOGY

Research Objectives and Scope

  • Methodology
  • Assumptions and Limitations

5. INDUSTRY CHALLENGES

Industry Challenges for the European Head and Neck Cancer Therapeutics Markets

  • Challenges Faced by Pharmaceutical Companies

6. TOTAL EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Overview and Definitions

  • Introduction
  • Market Drivers
  • Market Restraints
  • Current Therapeutic Options
  • Future Therapeutic Approaches
  • Current Treatment Guidelines
  • Pricing Trends
  • Market Engineering Measurement Analysis

Competitive Analysis

  • Profiles of Key Industry Participants and Market Share Analysis
  • Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Forecasts

  • Patient Forecasts
  • Market Revenue Forecasts
  • Geographical Trends
  • Forecasts of Recent Entrants - Erbitux

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursement Issues

  • Pricing and Reimbursement

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

  • Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • Key Participants in the Head and Neck Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

  • Prevalence of Smokers
  • Prevalence of Male Smokers
  • Prevalence of Female Smokers
  • Alcohol Consumption

Healthcare Expenditure

  • Expenditure
  • Pharmaceutical R&D Expenditure

Demography

  • Female Population Aged 65 Years and Above
  • Male Population Aged 65 Years and Above
  • Population Aged 65 Years and Above
  • Percent of Population Aged 65 Years and Above
Back to Top